# Clustering Approach 4 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.161863167526246	Range of duration = 0.03 to 223.4, nDeath = 61, nCensor = 469
2	AGE	ANOVA	0.00150312449877805	Range of values = 26 to 90, Mean = 57.8011, StdDev = 13.0546, nMissing = 1
3	GENDER	Chi-square test	0.0711875864025104	nTypes = 2 (FEMALE/MALE), nPatients = 553/6
4	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.182531808068634	nTypes = 2 (NO/YES), nPatients = 147/412
5	DISTANT.METASTASIS	Chi-square test	0.74475051952072	nTypes = 4 (CM0 (I+)/M0/M1/MX), nPatients = 1/481/6/71
6	LYMPH.NODE.METASTASIS	Chi-square test	0.328475916599209	nTypes = 15 (N0/N0 (I+)/N0 (I-)/N0 (MOL+)/N1/N1A/N1B/N1C/N1MI/N2/N2A/N3/N3A/N3B/NX), nPatients = 152/14/79/1/72/84/23/2/14/38/41/13/17/2/7
7	NUMBER.OF.LYMPH.NODES	ANOVA	0.273124069917462	Range of values = 0 to 35, Mean = 2.46821, StdDev = 4.62602, nMissing = 40
8	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 559
9	NEOPLASM.DISEASESTAGE	Chi-square test	0.0397889925796209	nTypes = 12 (STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV/STAGE X), nPatients = 47/42/2/8/181/126/2/95/15/29/6/5, nMissing = 1